Background: Cemento-ossifying Fibroma is a benign neoplasm related to bone that was first described by Menzel in 1842. This pathology can occur at any age, but is more common in young adults showing predilection for the jaw bone and female gender. Usually, the lesion is asymptomatic. It is well circumscribed and delimited by the surrounding bone, which generally allows its enucleation. However, some cases may require surgical resection and bone grafting.

Background: Face sinus mucocele is a collection of mucus that causes expansion and dilation of the sinus walls, like a cyst. The involvement of frontal sinus is not considered rare and as a result of a chronic infection, it becomes mucopyocele. Surgical approaches are based on the size, location and extent of mucocele in order to prevents recurrence.

Background: The arteriovenous malformations (AVM) are congenital alterations of the blood vessels, and in rare cases, they emerge only in adulthood. AVM present direct communications between an artery and a vein bypassing the capillary bed. They can occur at any area of the body and have gradual onset and progression.

Background: During 2016, the number of international travelers was over one billion, and it is still rising. Many of them travel to yellow fever (YF) risk areas and/or to areas where the vaccine is required. The current global shortage for vaccine production, along with the risk of serious adverse effects in certain traveler groups, means that we must make proper and rational use of the vaccine. The objective was to discuss whether the application of the YF vaccine in travelers is appropriate and rational. Methods & Materials: A voluntary survey was carried out among the travelers that received the YF vaccine at the Vaccination Center of a public hospital in the province of Buenos Aires between July-September 2017. Results: A total of 163 surveys were analyzed. Average age was 35 years (10-59). Immunocompromised 0.6%. No pregnant women. Median days before the trip 20 (0-133). Main destinations: South America 65% (Brazil 22%), Southeast Asia 15.5% (Thailand 13%) and Central America and Caribbean 9% (Bahamas 3%). They corresponded to: risk areas 27%, areas with vaccine requirement 29%, and risk areas with vaccine requirement 11.5%. 32.5% did not correspond to risk areas or areas with vaccine requirement. Reasons why they reported to be receiving the vaccine: requirement of the country to be visited 28%, medical advice 24%, recommendation by travel agency 19.5%, recommendation of family/friends 13%, media recommendation 8.5%, just because 4%, thinks he/she is at risk of getting sick 3%. Among those that had no indication (n = 53), the main reasons were: recommendation by travel agency 28.5%, recommendation of family/friends 26.5% and media recommendation 17%. 62% did not make a prior medical consultation. Conclusion: Almost a third of the travelers had no indication of getting the vaccine and they received it based, mainly, on recommendations received from travel agencies, family or friends, or the media. Despite the existence of a Travel Medicine Center within the same hospital, more than half of them did not make a prior medical consultation. Given the global shortage of the vaccine, we believe that medical evaluation can be a strategy to determine the real need for vaccination and to optimize its use.

Clinical OtolaryngologyVolume 43, Issue 1 p. 340-343 CORRESPONDENCE: OUR EXPERIENCE Posterior cordotomy in bilateral vocal cord paralysis using monopolar microelectrodes and radiofrequency in 18 patient J. Basterra, Corresponding Author J. Basterra jorge.basterra@uv.es orcid.org/0000-0002-8939-6317 ENT Unit, Surgical Department, Valencia Medical School, University General Hospital, University of Valencia, Valencia, Spain Correspondence J. Basterra, ENT Unit, Surgical Department, Valencia Medical School, University General Hospital, University of Valencia, Valencia, Spain. Email: jorge.basterra@uv.esSearch for more papers by this authorY. Castillo-Lopez, Y. Castillo-Lopez ENT Unit, Centro Medico Nacional de Occidente, IMSS, Mexico City, MexicoSearch for more papers by this authorR. Reboll, R. Reboll ENT Unit, Surgical Department, Valencia Medical School, University General Hospital, University of Valencia, Valencia, SpainSearch for more papers by this authorE. Zapater, E. Zapater ENT Unit, Surgical Department, Valencia Medical School, University General Hospital, University of Valencia, Valencia, SpainSearch for more papers by this authorC. Olavarria, C. Olavarria ENT Unit, Surgical Department, Clinica Santa Maria, University Clinic Hospital of Chile, Santiago, ChileSearch for more papers by this authorF. Krause, F. Krause ENT Unit, Surgical Department, Clinica Los Condes, Santiago Militar Hospital, Santiago, ChileSearch for more papers by this authorR. Hernandez, R. Hernandez ENT Unit, Surgical Department, Valencia Medical School, University General Hospital, University of Valencia, Valencia, SpainSearch for more papers by this authorM. Torres, M. Torres ENT Unit, Surgical Department, Valencia Medical School, University General Hospital, University of Valencia, Valencia, SpainSearch for more papers by this authorF. Tocornal, F. Tocornal ENT Unit, Surgical Department, Clinica Los Condes, Santiago Militar Hospital, Santiago, ChileSearch for more papers by this author J. Basterra, Corresponding Author J. Basterra jorge.basterra@uv.es orcid.org/0000-0002-8939-6317 ENT Unit, Surgical Department, Valencia Medical School, University General Hospital, University of Valencia, Valencia, Spain Correspondence J. Basterra, ENT Unit, Surgical Department, Valencia Medical School, University General Hospital, University of Valencia, Valencia, Spain. Email: jorge.basterra@uv.esSearch for more papers by this authorY. Castillo-Lopez, Y. Castillo-Lopez ENT Unit, Centro Medico Nacional de Occidente, IMSS, Mexico City, MexicoSearch for more papers by this authorR. Reboll, R. Reboll ENT Unit, Surgical Department, Valencia Medical School, University General Hospital, University of Valencia, Valencia, SpainSearch for more papers by this authorE. Zapater, E. Zapater ENT Unit, Surgical Department, Valencia Medical School, University General Hospital, University of Valencia, Valencia, SpainSearch for more papers by this authorC. Olavarria, C. Olavarria ENT Unit, Surgical Department, Clinica Santa Maria, University Clinic Hospital of Chile, Santiago, ChileSearch for more papers by this authorF. Krause, F. Krause ENT Unit, Surgical Department, Clinica Los Condes, Santiago Militar Hospital, Santiago, ChileSearch for more papers by this authorR. Hernandez, R. Hernandez ENT Unit, Surgical Department, Valencia Medical School, University General Hospital, University of Valencia, Valencia, SpainSearch for more papers by this authorM. Torres, M. Torres ENT Unit, Surgical Department, Valencia Medical School, University General Hospital, University of Valencia, Valencia, SpainSearch for more papers by this authorF. Tocornal, F. Tocornal ENT Unit, Surgical Department, Clinica Los Condes, Santiago Militar Hospital, Santiago, ChileSearch for more papers by this author First published: 17 July 2017 https://doi.org/10.1111/coa.12940Citations: 4 Meetings at which parts of this manuscript were presented: 85th Annual Meeting of the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery, Dortmund, Germany, 28 May-1 June, 2014; 87th Annual Meeting of the German Society of Oto-Rhino-Laryngology Head and Neck Surgery, Düsseldorf, Germany, 4-7 May, 2016. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Citing Literature Volume43, Issue1February 2018Pages 340-343 RelatedInformation

You have accessJournal of UrologyProstate Cancer: Detection and Screening1 Apr 20111196 MODELS TO PREDICT PROSTATE CANCER AGGRESSIVINESS IN PATIENTS CANDIDATES TO BIOPSY WITH PSA 2.5–10 F. Gomez Veiga, J. Ponce, S. Pertega, S. Breijo, J. Dacal, M. Torres, I. Rodriguez, D. Lopez, S. Pita, and V. Ch. Abal F. Gomez VeigaF. Gomez Veiga A Coruña, Spain More articles by this author , J. PonceJ. Ponce A Coruña, Spain More articles by this author , S. PertegaS. Pertega A Coruña, Spain More articles by this author , S. BreijoS. Breijo A Coruña, Spain More articles by this author , J. DacalJ. Dacal A Coruña, Spain More articles by this author , M. TorresM. Torres A Coruña, Spain More articles by this author , I. RodriguezI. Rodriguez A Coruña, Spain More articles by this author , D. LopezD. Lopez A Coruña, Spain More articles by this author , S. PitaS. Pita A Coruña, Spain More articles by this author , and V. Ch. AbalV. Ch. Abal A Coruña, Spain More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2011.02.831AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Prostate biopsy is the standard method to diagnose prostate cancer (PC). Some concern exists over possibility to diagnose a high percent of insignificant tumors and overtreatment. The aim of this study is develop clinical nomograms to predict, PC aggressiveness on patients with psa 2.5–10 ng/ml. METHODS Prospective study of 3098 patients with PSA 2.5-10 ng/mL, referred consecutively for first biopsy, between September 2002 and December 2009. A sample of PSA and Complex PSA (cPSA) (Centaur®) was taken previous to biopsy and rectal examination. The technique to biopsy in all patients was TRU guided, 10 core biopsies were obtained. Factors associated with the results of biopsy were studied, including: age,DRE,PSA,cPSA, %c-tPSA and PSA density. Multiple logistic regression was used to simultaneously assess the association of clinical characteristics with the results of the biopsy. Three different outcomes were considered: i) cancer, ii) high grade cancer (Gleason score ≥ 7) and iii) more than 2 positive cores in biopsy. Nomograms were constructed based on the fitted multiple logistic regression models with a bootstrap resampling approach. Statistical analyses were performed by using SPSS version 17.0. RESULTS Of the 3098 patients, 1045 (33.7%) were found to have PC at biopsy. Of these, 536 (51.3%) had a Gleason score ≥7, and 603 (57.7%) were found to have PC at biopsy in >2 cores. All studied risk factors were found to be significantly associated with PC detection in the univariate analysis. Multivariate analysis showed that older age at biopsy, abnormal digital rectal examination, higher values of cPSA, %c-tPSA and PSA density were significantly associated with a higher probability of diagnosing PC and aggressiviness in the biopsy. Three nomograms were constructed to predict the presence of: i) , ii) and iii). These nomograms predict biopsy outcomes with good discrimination (Bootstrap corrected AUC's 0.76, 0.81 and 0.78 for i,ii,iii respectively). CONCLUSIONS Three nomograms are proposed to predict the diagnosis of PC and aggressive forms of PC at prostate biopsy in the 2.5-10 ng/mL PSA range. These tools could help clinicians to assess PC risk on an individual basis and make management decisions. © 2011 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 185Issue 4SApril 2011Page: e480 Advertisement Copyright & Permissions© 2011 by American Urological Association Education and Research, Inc.MetricsAuthor Information F. Gomez Veiga A Coruña, Spain More articles by this author J. Ponce A Coruña, Spain More articles by this author S. Pertega A Coruña, Spain More articles by this author S. Breijo A Coruña, Spain More articles by this author J. Dacal A Coruña, Spain More articles by this author M. Torres A Coruña, Spain More articles by this author I. Rodriguez A Coruña, Spain More articles by this author D. Lopez A Coruña, Spain More articles by this author S. Pita A Coruña, Spain More articles by this author V. Ch. Abal A Coruña, Spain More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...

Progress in immunosuppressive therapy and surgical practice experience in combined transplants has made possible that cardio-renal transplants (CRT) a successful option for treating patients that suffer from terminal heart disease and chronic renal failure. The aim of this study is to review the results of CRT in our center.

The development and widespread use of diagnostic tools and improved access to health favor the diagnosis of renal tumors. The aim of this study is to analyze the evolution over time of four parameters related to the patients and tumors: age, clinical presentation, tumor size and clinical stage.